The C-terminal tail of the bacterial translocation ATPase SecA modulates its activity
Abstract
In bacteria, the translocation of proteins across the cytoplasmic membrane by the Sec machinery requires the ATPase SecA. SecA can bind ribosomes and recognise nascent substrate proteins, but the molecular mechanism of recognition is unknown. We investigated the role of the C-terminal tail (CTT) of SecA in nascent polypeptide recognition. The CTT consists of a flexible linker (FLD) and a small metal-binding domain (MBD). Phylogenetic analysis and ribosome binding experiments indicated that the MBD interacts with 70S ribosomes. Disruption of the MBD only or the entire CTT had opposing effects on ribosome binding, substrate-protein binding, ATPase activity and in vivo function, suggesting that the CTT influences the conformation of SecA. Site-specific crosslinking indicated that F399 in SecA contacts ribosomal protein uL29, and binding to nascent chains disrupts this interaction. Structural studies provided insight into the CTT-mediated conformational changes in SecA. Our results suggest a mechanism for nascent substrate protein recognition.
Data availability
X-ray crystallography data are deposited in PDB under accession code 6GOX.Small-angle x-ray scattering data are deposited in SASBDB under accession codes SASDDY9, SASDDZ9 and SASDE22.
Article and author information
Author details
Funding
Biotechnology and Biological Sciences Research Council (BB/L019434/1)
- Mohammed Jamshad
- Damon Huber
Biotechnology and Biological Sciences Research Council (BB/P009840/1)
- Timothy J Knowles
- Gareth W Hughes
Biotechnology and Biological Sciences Research Council (MIBTP)
- Max Wynne
Deutsche Forschungsgemeinschaft (FOR 1805)
- Günter Kramer
- Bernd Bukau
Deutsche Forschungsgemeinschaft (SFB 638)
- Günter Kramer
- Bernd Bukau
Wellcome (099266/Z/12/Z)
- Fiyaz Mohammed
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Reviewing Editor
- Ramanujan S Hegde, MRC Laboratory of Molecular Biology, United Kingdom
Publication history
- Received: May 10, 2019
- Accepted: June 26, 2019
- Accepted Manuscript published: June 27, 2019 (version 1)
- Version of Record published: July 10, 2019 (version 2)
Copyright
© 2019, Jamshad et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,196
- Page views
-
- 315
- Downloads
-
- 5
- Citations
Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Biochemistry and Chemical Biology
- Structural Biology and Molecular Biophysics
A complex interplay between structure, conformational dynamics and pharmacology defines distant regulation of G protein-coupled receptors.
-
- Biochemistry and Chemical Biology
The glucagon-like peptide-1 receptor (GLP1R) is a broadly expressed target of peptide hormones with essential roles in energy and glucose homeostasis, as well as of the blockbuster weight-loss drugs semaglutide and liraglutide. Despite its large clinical relevance, tools to investigate the precise activation dynamics of this receptor with high spatiotemporal resolution are limited. Here, we introduce a novel genetically encoded sensor based on the engineering of a circularly permuted green fluorescent protein into the human GLP1R, named GLPLight1. We demonstrate that fluorescence signal from GLPLight1 accurately reports the expected receptor conformational activation in response to pharmacological ligands with high sensitivity (max ΔF/F0=528%) and temporal resolution (τON = 4.7 s). We further demonstrated that GLPLight1 shows comparable responses to glucagon-like peptide-1 (GLP-1) derivatives as observed for the native receptor. Using GLPLight1, we established an all-optical assay to characterize a novel photocaged GLP-1 derivative (photo-GLP1) and to demonstrate optical control of GLP1R activation. Thus, the new all-optical toolkit introduced here enhances our ability to study GLP1R activation with high spatiotemporal resolution.